337 related articles for article (PubMed ID: 22975849)
1. α-Lipoic acid interaction with dopamine D2 receptor-dependent activation of the Akt/GSK-3β signaling pathway induced by antipsychotics: potential relevance for the treatment of schizophrenia.
Deslauriers J; Desmarais C; Sarret P; Grignon S
J Mol Neurosci; 2013 May; 50(1):134-45. PubMed ID: 22975849
[TBL] [Abstract][Full Text] [Related]
2. Implication of the ERK/MAPK pathway in antipsychotics-induced dopamine D2 receptor upregulation and in the preventive effects of (±)-α-lipoic acid in SH-SY5Y neuroblastoma cells.
Deslauriers J; Desmarais C; Sarret P; Grignon S
J Mol Neurosci; 2014 Mar; 52(3):378-83. PubMed ID: 24203573
[TBL] [Abstract][Full Text] [Related]
3. Kainic acid-induced seizures modulate Akt (SER473) phosphorylation in the hippocampus of dopamine D2 receptor knockout mice.
Dunleavy M; Provenzano G; Henshall DC; Bozzi Y
J Mol Neurosci; 2013 Jan; 49(1):202-10. PubMed ID: 23188702
[TBL] [Abstract][Full Text] [Related]
4. Differential effects of amisulpride and haloperidol on dopamine D2 receptor-mediated signaling in SH-SY5Y cells.
Park SW; Seo MK; Cho HY; Lee JG; Lee BJ; Seol W; Kim YH
Neuropharmacology; 2011 Sep; 61(4):761-9. PubMed ID: 21663752
[TBL] [Abstract][Full Text] [Related]
5. Differential modulation of Akt/glycogen synthase kinase-3beta pathway regulates apoptotic and cytoprotective signaling responses.
Nair VD; Olanow CW
J Biol Chem; 2008 May; 283(22):15469-78. PubMed ID: 18387957
[TBL] [Abstract][Full Text] [Related]
6. Possible involvement of post-dopamine D2 receptor signalling components in the pathophysiology of schizophrenia.
Amar S; Shaltiel G; Mann L; Shamir A; Dean B; Scarr E; Bersudsky Y; Belmaker RH; Agam G
Int J Neuropsychopharmacol; 2008 Mar; 11(2):197-205. PubMed ID: 17681085
[TBL] [Abstract][Full Text] [Related]
7. Reduction of dopamine and glycogen synthase kinase-3 signaling in rat striatum after continuous administration of haloperidol.
Kimura M; Oda Y; Kimura H; Nangaku M; Hirose Y; Niitsu T; Kanahara N; Shirayama Y; Hashimoto K; Iyo M
Pharmacol Biochem Behav; 2021 Mar; 202():173114. PubMed ID: 33485878
[TBL] [Abstract][Full Text] [Related]
8. The effects of neuropsychiatric drugs on glycogen synthase kinase-3 signaling.
Sutton LP; Rushlow WJ
Neuroscience; 2011 Dec; 199():116-24. PubMed ID: 22001305
[TBL] [Abstract][Full Text] [Related]
9. Famotidine has a neuroprotective effect on MK-801 induced toxicity via the Akt/GSK-3β/β-catenin signaling pathway in the SH-SY5Y cell line.
Unal G; Dokumaci AH; Ozkartal CS; Yerer MB; Aricioglu F
Chem Biol Interact; 2019 Dec; 314():108823. PubMed ID: 31563592
[TBL] [Abstract][Full Text] [Related]
10. Signaling pathways leading to phosphorylation of Akt and GSK-3β by activation of cloned human and rat cerebral D₂and D₃ receptors.
Mannoury la Cour C; Salles MJ; Pasteau V; Millan MJ
Mol Pharmacol; 2011 Jan; 79(1):91-105. PubMed ID: 20952497
[TBL] [Abstract][Full Text] [Related]
11. Early effects of mood stabilizers on the Akt/GSK-3beta signaling pathway and on cell survival and proliferation.
Aubry JM; Schwald M; Ballmann E; Karege F
Psychopharmacology (Berl); 2009 Aug; 205(3):419-29. PubMed ID: 19440698
[TBL] [Abstract][Full Text] [Related]
12. Tardive dyskinesia is associated with altered putamen Akt/GSK-3β signaling in nonhuman primates.
Hernandez G; Mahmoudi S; Cyr M; Diaz J; Blanchet PJ; Lévesque D
Mov Disord; 2019 May; 34(5):717-726. PubMed ID: 30675935
[TBL] [Abstract][Full Text] [Related]
13. Transient and rapid activation of Akt/GSK-3β and mTORC1 signaling by D3 dopamine receptor stimulation in dorsal striatum and nucleus accumbens.
Salles MJ; Hervé D; Rivet JM; Longueville S; Millan MJ; Girault JA; Mannoury la Cour C
J Neurochem; 2013 May; 125(4):532-44. PubMed ID: 23410496
[TBL] [Abstract][Full Text] [Related]
14. Antagonism of dopamine D2 receptor/beta-arrestin 2 interaction is a common property of clinically effective antipsychotics.
Masri B; Salahpour A; Didriksen M; Ghisi V; Beaulieu JM; Gainetdinov RR; Caron MG
Proc Natl Acad Sci U S A; 2008 Sep; 105(36):13656-61. PubMed ID: 18768802
[TBL] [Abstract][Full Text] [Related]
15. Protective effects of olanzapine and haloperidol on serum withdrawal-induced apoptosis in SH-SY5Y cells.
Kim NR; Park SW; Lee JG; Kim YH
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Apr; 32(3):633-42. PubMed ID: 18055082
[TBL] [Abstract][Full Text] [Related]
16. DRD2/AKT1 interaction on D2 c-AMP independent signaling, attentional processing, and response to olanzapine treatment in schizophrenia.
Blasi G; Napolitano F; Ursini G; Taurisano P; Romano R; Caforio G; Fazio L; Gelao B; Di Giorgio A; Iacovelli L; Sinibaldi L; Popolizio T; Usiello A; Bertolino A
Proc Natl Acad Sci U S A; 2011 Jan; 108(3):1158-63. PubMed ID: 21187413
[TBL] [Abstract][Full Text] [Related]
17. Antipsychotic-induced DRD2 upregulation and its prevention by α-lipoic acid in SH-SY5Y neuroblastoma cells.
Deslauriers J; Lefrançois M; Larouche A; Sarret P; Grignon S
Synapse; 2011 Apr; 65(4):321-31. PubMed ID: 20730801
[TBL] [Abstract][Full Text] [Related]
18. Developmental effects of early-life stress on dopamine D2 receptor and proteins involved in noncanonical D2 dopamine receptor signaling pathway in the prefrontal cortex of male rats.
Mahmoodkhani M; Ghasemi M; Derafshpour L; Amini M; Mehranfard N
J Complement Integr Med; 2022 Sep; 19(3):697-703. PubMed ID: 33962496
[TBL] [Abstract][Full Text] [Related]
19. Deletion of GSK3β in D2R-expressing neurons reveals distinct roles for β-arrestin signaling in antipsychotic and lithium action.
Urs NM; Snyder JC; Jacobsen JP; Peterson SM; Caron MG
Proc Natl Acad Sci U S A; 2012 Dec; 109(50):20732-7. PubMed ID: 23188793
[TBL] [Abstract][Full Text] [Related]
20. (R)-(+)-α-lipoic acid protected NG108-15 cells against H₂O₂-induced cell death through PI3K-Akt/GSK-3β pathway and suppression of NF-κβ-cytokines.
Kamarudin MN; Mohd Raflee NA; Hussein SS; Lo JY; Supriady H; Abdul Kadir H
Drug Des Devel Ther; 2014; 8():1765-80. PubMed ID: 25336920
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
